Search results
Results From The WOW.Com Content Network
Alcon offices in Johns Creek, Georgia. Alcon Inc. ( German: Alcon AG) is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It has a paper headquarters in Geneva, Switzerland but its operational headquarters are in Fort Worth, Texas, United States, where it employs about 4,500 people. [2]
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Donate; Language links are at the top of the page.
Nepafenac, sold under the brand name Nevanac among others, is a nonsteroidal anti-inflammatory drug (NSAID), usually sold as a prescription eye drop 0.1% solution (Nevanac) or 0.3% solution (Ilevro). It is used to treat pain and inflammation associated with cataract surgery. [ 3] Nepafenac is a prodrug of amfenac, an inhibitor of COX-1 and COX ...
Alcon Entertainment, LLC is an American independent film and television production company, founded in 1997 by film producers Broderick Johnson and Andrew Kosove.Since its establishment, Alcon Entertainment has developed and financed films that are ultimately distributed – in the United States mostly, and internationally on occasion – by Warner Bros. Pictures, following a ten-year motion ...
Language links are at the top of the page across from the title.
Agency ID. T08GB0002C. The Agency for Science, Technology and Research ( A*STAR) is a statutory board under the Ministry of Trade and Industry of Singapore . The agency supports R&D that is aligned to areas of competitive advantage and national needs for Singapore. These span the four technology domains of Manufacturing, Trade and Connectivity ...
Tobramycin/dexamethasone, sold under the brand name Tobradex, is a fixed-dose combination medication in the form of eye drops and eye ointment, marketed by Alcon. [ 1][ 2][ 3] The active ingredients are tobramycin (an antibiotic) and dexamethasone (a corticosteroid ). [ 2] It is prescribed for the treatment of pink eye in combination with ...
The company was created as EPCOS AG in 1999 from Siemens Matsushita Components, which was a joint venture of Siemens and Matsushita in 1989. The stock opened on 15 October 1999 at the same time in Frankfurt and New York City, with Siemens and Matsushita holding interests of 12.5% each. In 2006, Siemens sold its shares of EPCOS.